Resonac Holdings Corporation

2026/11/11 12:12 Updated
Market Cap: $14.9B (¥2.4T)
Stock Price: $78.31 (¥12,410)
Exchange Rate: 1 USD = ¥158.48

Financial Summary for the Third Quarter of the Fiscal Year Ending December 2026 [IFRS] (Consolidated)

For the nine-month period of the fiscal year ending December 2026, consolidated revenue was 871,853 million yen, up 14.2% year-over-year. Core operating profit was 164,137 million yen, up 136.2% year-over-year. Operating profit was 148,350 million yen, and profit for the period attributable to owners of the parent was 94,640 million yen. Following the partial spin-off of Clathas Chemical, that business is presented as discontinued operations. Consolidated forecasts have been revised. There are special notes including the impact of an in-kind dividend.

Importance:
Page Updated: November 11, 2026
IR Disclosure Date: November 11, 2026

Key Figures

  • Revenue: 871,853 million yen
  • Core Operating Profit: 164,137 million yen
  • Operating Profit: 148,350 million yen
  • Profit for the Period Attributable to Owners of the Parent: 94,640 million yen
  • Total Assets: 2,173,299 million yen

AI要約

Overview of Results

For the cumulative third quarter period of the fiscal year ending December 2026, revenue was 871,853 million yen, up 14.2% year-over-year, and core operating profit increased significantly to 164,137 million yen. By segment, semiconductor and electronic materials, innovation materials, and chemicals achieved higher revenue and profits, while mobility remained generally solid despite periods affected by transfers. Operating profit rose substantially as prior impairment impacts did not recur. Following the partial spin-off of Clathas Chemical, that business has been classified as discontinued operations. The full-year forecast has been revised and disclosed.

Outlook, Dividends and Capital Policy

This quarterly financial summary notes revisions to the full-year earnings forecast, reflecting updates to consolidated performance expectations. The report describes the implementation of an in-kind dividend and changes in the handling of Clathas Chemical shares, which have increased liabilities related to the in-kind dividend and affected the financial position. The company has indicated that, after the new spin-off, equity-method accounting will be discontinued and the investment will be measured at FVTOCI.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Resonac Holdings Corporation

Company overview · Stock price · Financial data · All IR

View company page →